Talaris Therapeutics, Inc. — Form D

Talaris Therapeutics, Inc. of LOUISVILLE, KY, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-07. The offering totals $115.0M, of which $115.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2020-10-07
• Form: D
• Accession: 0001827506-20-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $115.0M
• Amount sold: $115.0M
• Investors: 24
• Date of first sale: 2020-09-22
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-377389

Issuer

• Name: Talaris Therapeutics, Inc.
• CIK: 0001827506
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 201 E. JEFFERSON ST., SUITE 110B, LOUISVILLE, KY, 40202
• Phone: 502-569-1059

Officers, directors & promoters (9)

More

• CIK 1827506 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search